CHICAGO, IL – In a move to provide improved absorption of dietary supplement and cosmeceutical ingredients, SourceOne™ Global Partners has announced it has formed a strategic alliance with Vesifact AG, headquartered in Baar, Switzerland. SourceOne will serve as the exclusive worldwide marketing partner whose role is to build and manage a strategic marketing and distribution infrastructure that delivers market access for Vesifact’s products and technologies.
Vesifact is a spin-off from the Swiss Federal Institute of Technology, Zurich (ETH Zurich). It represents a vital link between current research and private industry. Founded in 1987, the Vesifact Technology Transfer Unit was named after the primary research activities of company founder, Dr. Hans Georg Weder, Professor of Pharmaceutical Chemistry and Physical Pharmacy at the ETH Zurich. Marc Weder, a pharmacist and son of Dr. Weder, is also a co-founder of Vesifact and currently serves as the company’s CEO.
The VesiSorb® delivery system, developed by Vesifact, is protected worldwide by multiple U.S. and International granted and pending patents. The first product that Vesifact and SourceOne will introduce using this patented technology is CoQsource™ Bio-Enhanced CoQ10.
With CoQsource, peak absorption of 16.97% was achieved in a clinical study. This represents a significant improvement compared to reported peak absorption values of 2.15%, 3.34%, and 5.44% for CoQ10 in powder, oil dispersion, and lipid solution delivery systems respectively. This compelling data is evidence of the benefits this application technology delivers. A clinical study comparing CoQsource to three leading “bio-enhanced” formulas resulted in the VesiSorb delivery system achieving an AUC of 30.16 µg/ml/10h compared to AUC values of 5.14 µg/ml/10h, 5.72 µg/ml/10h, and 10.65 µg/ml/10h for the three competitive products in the study.
CoQsource is composed of millions of colloidal droplets that readily solubilize CoQ10 in the GI-tract thereby improving the transport of CoQ10 through the aqueous phase of the GI-lumen to the absorptive epithelium and hence its bioavailability.
“SourceOne, together with our Swiss partner, Vesifact, is extremely proud to introduce bio-enhanced ingredients and proprietary formulas containing CoQ10 in both the ubiquinone and ubiquinol forms, as well as OmegaSmart™ high potency EPA and DHA, Sytrinol®, PMFsource™ Citrus Bioflavonoids, TocoSource® Palm Tocotrienols, and other proprietary formulas that make up our Cholesstrinol™ family of products,” said Jesse Lopez, President and CEO of SourceOne. “Using this natural association colloid system, we can now meet the growing demand for enhanced bioavailability of these unique science-based ingredients and proprietary formulas taking their absorption and efficacy to the next level, truly making SourceOne your first choice for heart healthy ingredient solutions,” said Mr. Lopez.
“Vesifact chose to partner with SourceOne because of their extensive knowledge of the industry, global perspective and proven marketing success,” Marc Weder, CEO of Vesifact, said. “Establishing a presence in a marketplace is not an easy task, but SourceOne has had great success in bringing their suite of heart healthy ingredients to market. We look forward to leveraging this partnership as a vehicle to jointly deliver value with cutting-edge application technology,” added Mr. Weder.
“The need for supplementation with CoQ10 is clear and has never been greater, especially with the dramatic increase in the number of people taking statin drugs,” Dr. Hans Weder, President of Vesifact, stated. “The importance of improving absorption and efficacy is also quite evident,” he said.
Lopez also added, “SourceOne remains committed to delivering peerless value to the marketplace by following a two-prong approach: a) Superior-quality branded ingredients that are developed using proprietary technology, and b) Ingredients that are fully supported by compelling scientific studies. The investment in building new alliances with leading R&D companies, like Vesifact, is the foundation upon which we will continue to deliver new, innovative products, and build long-term relationships with our brand marketing and manufacturing customers.”
SourceOne’s stewardship in the alliance will encompass development of strategic marketing plans, leveraging cross-market segment synergies, and other partnership initiatives.
About SourceOne™ Global Partners
SourceOne™ Global Partners, headquartered in Chicago, IL, represents a new breed of ingredient supplier, partnering with manufacturing clients to introduce powerfully branded, science-driven products to market with unique product positioning and compelling consumer presence. SourceOne was conceived as a company whose core competency would be to integrate legitimate science with strong trade and consumer branding. They partner with leading suppliers worldwide to source and offer patented ingredients supported by proprietary science as part of turnkey marketing programs that dramatically increases the odds for market success.
About Vesifact AG
A vital link between current research and private industry, Vesifact is a spin-off from the Swiss Federal Institute of Technology, Zurich (ETH Zurich). Innovative technology and know-how are developed in Vesifact’s laboratories and upscaled at its production units. They are then applied to commercial products before being transferred to the marketplace. In this way, Vesifact brings the latest know-how to exactly where it is most needed.
Vesifact’s laboratory and R&D facilities meet the ever increasing requirements for top-level research, product development, and innovation. Vesifact produces carrier systems that improve absorption of medical, nutraceutical, and cosmetic ingredients to enhance performance. Vesifact thus fulfils ever-increasing requirements for innovative dosage forms and application technologies, and offers cutting-edge solutions.